Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRTA
3026
Strata Critical Medical Inc
SRTA
$434M
| $720K | ﹤0.01% |
169,443
-674
| -0.4% | -$2.57K |
|
|
EEX
3027
DELISTED
Emerald Holding
EEX
| $720K | ﹤0.01% |
149,298
+1,097
| +0.7% | +$5.04K |
|
3028
Seres Therapeutics
MCRB
$46.8M
| $720K | ﹤0.01% |
43,291
+5,855
| +16% | +$95.1K |
|
3029
ASP Isotopes
ASPI
$504M
| $717K | ﹤0.01% |
158,226
+37,948
| +32% | +$202K |
|
3030
ICL Group
ICL
$6.53B
| $717K | ﹤0.01% |
145,072
+66,933
| +86% | +$299K |
|
3031
Jakks Pacific
JAKK
$301M
| $716K | ﹤0.01% |
25,449
+1,258
| +5% | +$34.5K |
|
3032
Angi Inc
ANGI
$229M
| $715K | ﹤0.01% |
43,061
+467
| +1% | +$9.96K |
|
3033
Trevi Therapeutics
TRVI
$2.59B
| $713K | ﹤0.01% |
173,063
+22,145
| +15% | +$70.9K |
|
3034
Children's Place
PLCE
$54.3M
| $713K | ﹤0.01% |
68,122
-61,090
| -47% | -$802K |
|
3035
Backblaze
BLZE
$823M
| $712K | ﹤0.01% |
118,349
+193
| +0.2% | +$1.31K |
|
3036
Red River Bancshares
RRBI
$662M
| $704K | ﹤0.01% |
13,043
| – | – |
|
3037
Fresenius Medical Care
FMS
$13.8B
| $704K | ﹤0.01% |
31,074
+8,913
| +40% | +$193K |
|
3038
John Marshall Bancorp
JMSB
$327M
| $696K | ﹤0.01% |
34,646
| – | – |
|
3039
Neurogene
NGNE
$656M
| $693K | ﹤0.01% |
30,317
| – | – |
|
3040
Ocugen
OCGN
$416M
| $692K | ﹤0.01% |
860,244
+93,288
| +12% | +$85.4K |
|
3041
Primis Financial Corp
FRST
$399M
| $692K | ﹤0.01% |
59,342
+18
| +0% | +$216 |
|
3042
Jasper Therapeutics
JSPR
$21M
| $691K | ﹤0.01% |
32,337
-70
| -0.2% | -$1.46K |
|
3043
Donegal Group Class A
DGICA
$731M
| $688K | ﹤0.01% |
44,492
+1,773
| +4% | +$27.6K |
|
3044
Acrivon Therapeutics
ACRV
$64.2M
| $685K | ﹤0.01% |
113,840
-2,413
| -2% | -$17.5K |
|
3045
Radiant Logistics
RLGT
$386M
| $683K | ﹤0.01% |
101,895
| – | – |
|
|
TE
3046
T1 Energy
TE
$1.16B
| $682K | ﹤0.01% |
264,505
| – | – |
|
3047
Aldeyra Therapeutics
ALDX
$92.9M
| $682K | ﹤0.01% |
136,733
| – | – |
|
3048
MeiraGTx Holdings
MGTX
$1.09B
| $682K | ﹤0.01% |
112,021
+12,961
| +13% | +$76K |
|
|
HDSN
3049
Hudson Technologies
HDSN
$254M
| $681K | ﹤0.01% |
122,056
| – | – |
|
3050
Amplify Energy
AMPY
$161M
| $680K | ﹤0.01% |
113,377
| – | – |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.